It’s been more than 15 years since the last Harry Potter book hit shelves, yet we’re still enthralled with its magical world. That’s because the exciting tale is filled with epic bravery and heroics, ...

Lilly Evans was described as the most beautiful girl in her year ... extremely beautiful to the point that her beauty captivated everyone once she arrived at Hogwarts the year the Triwizard Tournament ...

It is tailored to patients being treated with Lilly's oncology drugs – which include blockbuster CDK 4/ 6 inhibitor Verzenio (abemaciclib) for hormone receptor-positive, HER2-negative breast ...

Drugs from Eli Lilly and Boehringer Ingelheim grabbed the spotlight at the EASL congress on liver diseases, both showing promising results in metabolic dysfunction-associated steatohepatitis (MASH).

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

Eli Lilly has agreed a deal to acquire French antibody-drug conjugate (ADC) specialist Mablink, continuing a series of transactions that build its position in what has become one of the fastest ...

Eli Lilly is just weeks away from launching Mounjaro in the UK, after getting approval from medicines regulator, the MHRA, for a new formulation of the drug as a treatment for diabetes and obesity.

The launch of the NovoCare Pharmacy service follows the removal of semaglutide – the active ingredient in Wegovy – from the FDA's shortage list and comes a few months after rival Eli Lilly ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...

Megan McKenna has married her fiancé Oliver Burke in a romantic ceremony held at Grantley Hall in North Yorkshire. The former TOWIE star, 32, looked incredible on the day in a flowing white ...

PT101 is an engineered IL-2 mutein fused to a protein backbone, and is vying to come to market along with other IL-2-based therapies, notably Eli Lilly and Nektar Therapeutics’ phase 2 candidate ...